$2.47
-0.01 (-0.40%)
Open$2.46
Previous Close$2.48
Day High$2.50
Day Low$2.41
52W High$8.54
52W Low$2.29
Volume—
Avg Volume237.5K
Market Cap109.95M
P/E Ratio—
EPS$-0.87
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+117.4% upside
Current
$2.47
$2.47
Target
$5.37
$5.37
$3.28
$5.37 avg
$6.50
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.9K | 98.8K | 62.40M |
| Net Income | -38,334,860 | -384,630,702 | -13,759,336 |
| Profit Margin | -401,812.5% | -381,721.9% | -22.1% |
| EBITDA | -39,314,622 | -416,375,595 | -15,040,886 |
| Free Cash Flow | — | — | -13,384,851 |
| Rev Growth | -91.0% | -91.0% | +12.2% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |